|
Arm
|
‘group’
|
‘individual’
|
‘standard’
|
|---|
|
Mean (SD), n
|
|
EQ-5D pre
|
0.545 (0.255), 19
|
0.480 (0.250), 20
|
0.555 (0.274), 19
|
|
EQ-5D 14w
|
0.639 (0.308), 17
|
0.660 (0.227), 14
|
0.560 (0.271), 13
|
|
OKS pre
|
22.8 (7.4), 20
|
22.4 (6.8), 20
|
24.2 (5.8), 20
|
|
OKS 14w
|
32.3 (11.1), 17
|
29.6 (7.7), 15
|
27.2 (7.7), 13
|
|
Using NSAID daily, n/N
|
|
pre
|
11/20 (55 %)
|
8/20 (40 %)
|
10/20 (50 %)
|
|
14w
|
5/17 (29 %)
|
4/14 (29 %)
|
7/14 (50 %)
|
|
Troublesomea, n/N
|
|
pre
|
7/20 (35 %)
|
9/20 (45 %)
|
5/20 (25 %)
|
|
14w
|
3/17 (18 %)
|
2/15 (13 %)
|
3/14 (21 %)
|
|
Global changeb
n/N
|
|
14w
|
7/17 (41 %)
|
9/15 (60 %)
|
2/14 (14 %)
|
- Pre baseline, 14w 14 week follow-up, ‘group’ group acupuncture, ‘individual’ individual acupuncture, ‘standard’ standardised care only, NSAID non-steroidal anti-inflammatory drug
- aHighest two categories, extremely and very
- bHighest two categories, much or moderately better
